By Chris Wack

 

Shares of Avalon GloboCare Corp. (AVCO) rose 12% to $2.35 after the company announced a strategic partnership with GE Healthcare.

The clinical-stage global developer of cell-based technologies and therapeutics said the partnership will accelerate Avalon's standardization, automation and bio-production for clinical-grade Chimeric Antigen Receptor cells and other immune-effector cells for cellular immunotherapy.

Both Avalon and GE Healthcare will strategically establish automated and standardized GMP cell production capabilities. Avalon will be given access to GE Healthcare's cell processing expertise and products in the form of FlexFactory Cell Therapy platform, FastTrak process development and training services.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

July 23, 2019 09:55 ET (13:55 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
General Electric (NYSE:GE)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more General Electric Charts.
General Electric (NYSE:GE)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more General Electric Charts.